The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Isis Pharmaceuticals Inc since year 2005.
The trader's CIK number is 874015.
At the time of the last reporting, Isis Pharmaceuticals Inc was the 10% Owner of Akcea Therapeutics, Inc. .
(stock ticker symbol AKCA).
See this page for all insider trading activities at Akcea Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-04-17||AKCA||Akcea Therapeutics, Inc.||Buy||10,666,666||18.75||199,999,987|
|2017-07-19||AKCA||Akcea Therapeutics, Inc.||Buy||3,125,000||8.00||25,000,000|
|2015-07-17||RGLS||Regulus Therapeutics Inc.||Sale||111,000||10.21||1,133,754|
|2015-07-16||RGLS||Regulus Therapeutics Inc.||Sale||167,000||10.79||1,801,429|
|2015-07-15||RGLS||Regulus Therapeutics Inc.||Sale||65,133||10.76||700,961|
|2015-06-30||RGLS||Regulus Therapeutics Inc.||Sale||13,248||10.79||143,012|
|2012-10-10||RGLS||Regulus Therapeutics Inc.||Buy||750,000||4.00||3,000,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Isis Pharmaceuticals Inc (10% Owner of Akcea Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.